At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 30 enrolled
Drug / intervention
Low dose Hydrocortisone +1 moredrug
Likely dose
Low dose Hydrocortisone 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind Crossover Within Subject Study on Low-Dose Hydrocortisone for Fibromyalgia
In Brief
A Early Phase 1 clinical trial evaluating Low dose Hydrocortisone and Placebo for Fibromyalgia. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This study is based on clinical findings that some patients with fibromyalgia have a tendency towards lower levels of the stress hormone cortisol. The hypothesis to be tested in this study is that the administration of a very low-dose of cortisol which has no side effects corrects this deficiency and results in an improvement of symptoms
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesGermany
CollaboratorsUniversity of Zurich
Timeline
Early Ph 1CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2003
First PostedOct 2005
Primary CompletionMay 2007
Study CompletionJun 2007
TodayJul 2026
First PostedOct 12, 2005
Enrollment StartMay 1, 2003
Primary CompletionMay 1, 2007
Study CompletionJun 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 20.7 years ago
Interventions
Low dose Hydrocortisonedrug
Hydrocortisone 10 mg daily
Placebodrug
Placebo